어플

US GEM invests 30 billion won in PCL

Business / 김지선 / 11/27/2023 12:50 AM
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] According to the industry on the 27th, PCL will receive an investment of 30 billion won from GEM, a global long-term investment manager. Funds will be secured by February next year through a third-party allocation method of paid-in capital increase.

GEM is a global long-term investment management company based in New York, USA, and operates venture capital and private equity funds worth about 4.5 trillion won.

The issuance price per share of new shares has yet to be determined, but the industry estimates it to be around 4,000 won. In terms of this, GEM is estimated to acquire about 7.5 million shares. Considering GEM's 4 million share acquisition contract signed with PCL CEO Kim So-yeon on the 15th, GEM will secure a total of 11.5 million shares.

Shares rose sharply on the news that PCL succeeded in attracting large-scale investment. On the KOSDAQ market on the 24th, PCL closed at 3,850 won, up 180 won (4.90%) from the previous trading day. Shares of PCL started at 2,650 won on the 16th, a day after news broke that GEM would acquire 4 million shares, and rose to 2,920 won, up 10.19 percent on the same day alone. Compared to the closing price of 2,500 won on the 15th, it has surged 54% in just nine days.

PCL said GEM will acquire about a 20% stake and become the second-largest shareholder, but some in the industry have raised the possibility that GEM may become the largest shareholder and change the largest shareholder.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

Mirae Asset Explores Allocation of SpaceX IPO Shares to Korean Investors
DB Group Founder Kim Jun-ki Summarily Indicted Over Omission of Affiliate Disclosure
Court Rules Against Sanction on Former KB Securities CEO in Lime Fund Scandal
Former Shinhan Card Vice President Gets Suspended Sentence Over Hiring Irregularities
NAVER CEO Meets French President Macron to Explore AI and Tech Collaboration
comments >

SNS